Alnylam Pharmaceuticals Inc (ALNY) support and resistance · P/E 76, rev $1.29B
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
This page maps Alnylam Pharmaceuticals Inc (ALNY) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new ALNY 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the ALNY quote page for the session range and the stock page for the full model.
Not investment advice.